Following a number of warning letters in June, the FDA is now recommending that 7-hydroxymitragynine (7-OH) be scheduled under the Controlled Substances Act. The administration is "specifically targeting 7-OH" — a highly potent opioid alkaloid derived from kratom. These products, often sold as gummies, shots, and drink mixes, pose serious risks to consumers and are not legally permitted as dietary supplements, foods, or approved drugs. From a LegitScript perspective: ✅ For Marketplaces: This means proactively removing 7‑OH and kratom listings and enforcing stricter merchant vetting. ✅ For Payment Providers: It means refusing CNP payments for merchants selling 7‑OH products, categorizing them as prohibited, and monitoring transactions closely. ✅ For Consumers: It’s about preventing exposure to dangerous and unapproved products. Enforcement is ramping up and 7-OH products and sellers are in the crosshairs. Platforms, acquirers, and PSPs must take swift action to ensure they are not enabling its sale. https://lnkd.in/gtHK6UF2 #Compliance #MarketplaceIntegrity #Payments #Kratom
LegitScript
Technology, Information and Internet
Portland, Oregon 5,376 followers
Making the internet and payment ecosystems safer and more transparent — now and for future generations.
About us
LegitScript, the global leader in Risk Management and Compliance Solutions, is trusted by the world’s largest search engines, e-commerce marketplaces, payment service providers, and social media platforms. By combining advanced, AI-driven technology with deep domain expertise and curated market intelligence, LegitScript empowers businesses to stay ahead of emerging threats and seize new growth opportunities with precision and speed. Our global team of regulatory experts and analysts is skilled at understanding global regulatory changes and assessing risk across products, websites, merchants, and platforms, providing clients with unmatched accuracy, actionable insights, and exceptional support.
- Website
-
https://www.legitscript.com
External link for LegitScript
- Industry
- Technology, Information and Internet
- Company size
- 201-500 employees
- Headquarters
- Portland, Oregon
- Type
- Privately Held
- Founded
- 2007
- Specialties
- Compliance, Merchant Monitoring, Transaction Laundering Detection, Internet Monitoring, Brand Monitoring, Cybercrime Research, Internet Pharmacies, Pharmacy Certification, Addiction Treatment Certification, High-Risk Merchant Data, Supplement Product Data, and Online Investigations
Locations
-
Primary
111 SW 5th Ave, Ste 2700
Portland, Oregon 97204, US
Employees at LegitScript
Updates
-
CFO's new article reveals how a strong CFO–CTO partnership is fueling LegitScript’s next chapter of innovation and scale. Jaylene Kunze joined as CFO in March and assumed the additional title of COO in June, as the company prepares for its next phase of growth. LegitScript’s annual revenue currently sits at $50 million to $75 million, with targets nearly double that. Tom Cook joined in January as CTO to deliver future value through product and platform innovation, while staying grounded in cost structure and strategic discipline. This partnership extends beyond product and performance, it’s also central to how the company manages cybersecurity and compliance risk. Their shared accountability is especially critical under private equity ownership, where value creation narratives are under constant scrutiny. Read the article 👉 https://gag.gl/Bt8NpD #CFOLeadership #CFOInsights #Payments #MarketplaceMonitoring #MerchantMonitoring
-
🚨 New Webinar: Social Gaming & Sweepstakes Casinos July 16 | 1 PM ET / 10 AM PT | 1 ETA CE Credit Online gambling is evolving fast — and so are the risks. Join policy expert Andrew Bayley to explore: - Emerging gambling models - Loopholes in U.S. regulations - Risks for payment providers - Enforcement challenges Register Here: https://ter.li/e2fdbp #payments #gambling #compliance #ETA
-
-
We’re proud to announce that LegitScript is now certifying UK-based telemedicine providers for advertising eligibility on Google platforms. This certification opens new doors for providers in a booming industry — with UK telehealth projected to grow to $7.55B by 2030. LegitScript helps ensure these providers meet key compliance and transparency standards, giving patients peace of mind and businesses the visibility they need. Read the full press release: https://ter.li/92pq7o #DigitalHealth #TelemedicineUK #Healthcare #OnlineCompliance
-
Last chance to sign up for tomorrow's webinar and get all your questions answered about how a LegitScript Healthcare Merchant Certification is essential for growing your business. Can't attend? Register anyway and we'll send you the recording. Register Today: https://ter.li/c1g7pn
-
-
LegitScript reposted this
In our latest customer spotlight, Corepay shares how partnering with LegitScript helps them: - Mitigate risk for their clients - Maintain strict compliance standards - Offer sustainable, long-term payment processing solutions https://gag.gl/QO8zaK
-
-
A new week means another new customer spotlight. Today, we're featuring our Enterprise Certification Partner, Corepay. Among other things, they help healthcare merchants meet the compliance standards required for modern banking relationships in regulated industries. Read more: https://ter.li/f6g67q Operate in a regulated industry and looking to improve your banking relationships? Join our June 25th webinar: https://ter.li/c1g7pn
-
-
We're excited to announce our upcoming webinar with our partner, Corepay: "The Importance of Bank Relationships in 2025: Why Certification is Your Passport." This webinar will showcase the benefits for merchants who obtain a LegitScript Merchant Certification and their ability to grow their businesses by processing payments in high-risk categories. Register Today: https://ter.li/b68to0
-
-
🚨 Tomorrow: Online Abortion Pill Sales — What Platforms Need to Know 📅 June 11 | 1 p.m. ET / 10 a.m. PT As demand for abortion medications online grows, so do the risks — from deceptive ads to unapproved pill sales. Platforms, ad networks, and payment providers are facing increased scrutiny and evolving compliance challenges. ✅ Navigate complex, changing regulations ✅ Identify and remove risky or noncompliant content ✅ Monitor activity at scale ✅ Minimize brand and legal exposure ✅ Hear about our new Risk Landscape Reports 🎙 Featuring: Clay Moore, Nicole Briggs, and Kristy Naylor 👉 Register now: https://ter.li/2rkyun #TrustAndSafety #Compliance #PlatformRisk
-
Pharmaceutical manufacturers face more scrutiny than ever, and compliance now plays a central role in safeguarding patient safety and brand trust. Our latest blog explores why the stakes have never been higher for manufacturers, distributors, and their partners. From rising regulatory scrutiny to the risk of being linked to illegal online sales, pharmaceutical companies must be proactive when it comes to compliance. Learn how certification and real-time monitoring can strengthen your credibility and help you stay ahead of risk. Keep Reading: https://ter.li/wne5zu #compliance #trustandsafety #pharma #platfomrisk